This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
 TheHealth-Care LawandYou


The ‘Sunshine’ provision of the new health-care-reform lawwill soon go


into effect—with definite implications for medical exhibitors and, by extension, medical trade shows. Meeting planners need to educate themselves now.


BY HUNTER R. SLATON


aConvene reader told us about a session he’d recently attended at the Healthcare Convention & Exhibitors Association’s (HCEA) Healthcare Convention MarketingSummit, which was held on Jan. 20 at the GaylordNational Resort &Convention Center, just outsideWashington, D.C.One of themost provocative topics dur- ing the session—a “Compliance Think Tank” panel discussion that featured an executive from a pharmaceutical com- pany, as well as current and former officials from the U.S. Food and Drug Administration—was a provision in last year’s health-care-reform law that could have major implications for medical trade shows. But even though it goes into effect next Janu- ary, many industry professionals don’t seem to have it on their radar. The provision in question—part of


the Patient Protection and Affordable Care Act (PPACA) signed into law inMarch 2010 —mandates that “manufacturer[s] of a covered drug, device, biological, ormedical supply” report to the U.S. Department of Health&HumanServices (HHS) any “pay- ment or transfer of value” to “covered recipients,” which at pres- ent means physicians and teaching hospitals, although this


40 pcmaconvene April 2011 “Until the final


language is made public, everybody’s guessing. All anyone can do is guess or tell you what they’ve heard.”


definition could be expanded. The discussion on this topic dur- ing theHCEAsession,Convene’s source said, turned to theways in which medical trade-show organizers might be asked to assist these manufacturers—that is, their exhibitors —in gathering the information required by the new law; and how, if organizers prove unwilling or unable to assist them in this endeavor, some companies might stop exhibiting. And that’s something that no one


wants.


Industry’s Problem? In our initial research, itwas easy to turn up a number of meeting pro- fessionals who either weren’t aware


of these impending reporting provi- sions or were sure that they had noth-


ing to do with them — that it was “industry’s problem,” meaning the phar- maceutical and medical-device industries. “I have not heard anything about this at all,”


one source told Convene.“We have a couple of pharma


companies at our showwhohave very strict compliance depart- ments—nothing has been indicated to us at this time.” Another source said: “It is not on our radar yet, because the rule does not


www.pcma.org


Afewmonthsago,


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118